Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wingard, 1995, Importance of Candida species other than C. albicans as pathogens in oncology patients, Clin Infect Dis, 20, 115, 10.1093/clinids/20.1.115
Abi Said, 1997, The epidemiology of hematogenous candidiasis caused by different Candida species, Clin Infect Dis, 24, 1122, 10.1086/513663
Voss, 1996, Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals, Eur J Clin Microbiol Infect Dis, 15, 909, 10.1007/BF01690507
Eubanks, 1993, Candida sepsis in surgical patients, Am J Surg, 166, 617, 10.1016/S0002-9610(05)80666-X
Abele-Horn, 1996, A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemicCandida infections in intensive care patients, Infection, 24, 426, 10.1007/BF01713042
Voss, 1997, Candidemia in intensive care unit: patients risk factors for mortality, Infection, 25, 8, 10.1007/BF02113499
Pappas, 1997, Current trends in nosocomial candidemia: results of a large multicenter study. Abstract No. 13, Abstracts of the IDSA 35th Annual Meeting, Clin Infect Dis, 25, 357
Papafrangis, 1998, Incidence of Candida spp. in intensive care units. Abstract No. 319, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 980
Fraser, 1992, Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality, Clin Infect Dis, 15, 414, 10.1093/clind/15.3.414
Nguyen, 1995, , Tanner DC. Therapeutic approach in patients with Candidemia, Arch Int Med, 155, 2429, 10.1001/archinte.1995.00430220087009
Stamos, 1995, Candidemia in a pediatric population, Clin Infect Dis, 20, 571, 10.1093/clinids/20.3.571
Roilides, 1997, Invasive candidiasis in pediatric patients, Clin Microbiol Infect, 3, 192, 10.1111/j.1469-0691.1997.tb00597.x
Lecciones, 1992, Lee JW, Navano EE. Vascular catheter- associated fungemia in patients with cancer: analysis of 155 episodes, Clin Inf Dis, 14, 875, 10.1093/clinids/14.4.875
Walsh, 1995, Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens and improved outcome with antifungal therapy, Clin Infect Dis, 20, 900, 10.1093/clinids/20.4.900
White, 1997, Epidemiology of invasive candidiasis, Internatl J Infect Dis, 51, 7
Krcmery, 1999, Candidemia in cancer patients: Risk factors and outcome in 140 episodes from a single cancer institution, Acta Chemoth, 5, 133
Noskin, 1996, Treatment of candidaemia with amphotericin B colloidal dispersion. Abstract No. 78, Abstracts of the IDSA 34th Annual Meeting, Clin Infect Dis, 23, 874
Rex, 1995, For the NIAID Mycoses Study Group and the Candidemia Study Group: Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia, Antimicrob Agents Chemother, 39, 40, 10.1128/AAC.39.1.40
Bloomberg, 1998, Risk factors for Candida bloodstream infections in surgical ICUs. Abstract No. 102, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 939
Huttova, 1998, Candida fungemia in neonates treated with fluconazole, Pediatr Infect Dis J, 17, 12, 10.1097/00006454-199811000-00010
Kaiserova, 1998, Fungemia in children with cancer, Pediatr Infect Dis J, 19, 844
Levy, 1998, Emergence of Candida parapsilosis as the predominant species causing candidemia in children, Clin Infect Dis, 26, 1086, 10.1086/520277
Bisbe, 1992, Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review, Clin Infect Dis, 15, 910, 10.1093/clind/15.6.910
Pappas, 1998, Candidemia in the United States. Abstract No. 320, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 981
Abi Said, 1998, Epidemiology of Non-albicans Candida spp, Bailliere's Clinical Infect Dis, 7, 1131
Pic Alaus, 1998, Risk factors for candidemia caused by non-albicans Candida spp. Abstract No. 321, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 981
Kralovicova, 1997, Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome, Scand J Infect Dis, 29, 1226, 10.3109/00365549709019047
Krcmery, 1998, Risk factors and outcome of non-albicans candidemia: Report of 38 cases, Acta Chemother, 8, 23
Rex, 1995, Resistance of Candida species to fluconazole, Antimicrob Agents Chemother, 39, 1, 10.1128/AAC.39.1.1
Bille, 1997, Evaluation of the susceptibility of pathogenic Candida species to fluconazole, Eur J Clin Microbiol Infect Dis, 16, 924, 10.1007/BF01700561
Nguyen, 1998, Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia, J Infect Dis, 177, 425, 10.1086/514193
Blumberg, 1996, Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer, Clin Infect Dis, 22, 462, 10.1093/clinids/22.3.462
Krcmery, 1997, Breakthrough fungemia during therapy with amphotericin B, Chemotherapy, 42, 139
Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 326, 845, 10.1056/NEJM199203263261301
Anaissie, 1996, Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study, Am J Med, 101, 170, 10.1016/S0002-9343(96)80072-6
van't Wout, 1996, Fluconazole treatment of candidal infections caused by non-albicans Candida species, Eur J Clin Microbiol Infect Dis, 15, 238, 10.1007/BF01591361
Krcmery, 1998, Nosocomial breakthrough fungemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of etiology risk factors and outcome, J Antimicrob Chemother, 41, 373, 10.1093/jac/41.3.373
Kunova, 1995, Candida glabrata and Candida krusei, non-albicans Candida species and other fungal organisms in a sixty-bed national cancer center in 1989–1993: no association with the use of fluconazole, Chemotherapy, 41, 133, 10.1159/000239322
Iwen, 1995, Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole, Clin Infect Dis, 20, 342, 10.1093/clinids/20.2.342
Al Soub, 1997, Hospital acquired candidaemia experience from a developing country, J Hosp Infect, 35, 141, 10.1016/S0195-6701(97)90102-X
Clancy, 1998, Correlation of fluconazole MIC and response to therapy for patients with candidaemia due to C. albicans and non-albicans Candida spp. Abstract No. 98, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 938
Babinchak, 1997, Clinical outcome of Candida blood stream infection based upon antifungal susceptibility testing. Abstract No. 141, Abstracts of the IDSA 35th Annual Meeting, Clin Infect Dis, 25, 381
Lee, 1997, Correlation of antifungal susceptibility testing with clinical outcome. Abstract No. 145. Abstracts of the DSA 35th ASA Annual Meeting,, Clin Infect Dis, 25, 383
Doonquah, 1997, Fungemia in intensive care unit (ICU) patients. Abstract No. 149, Abstracts of the DSA ISDA 35th Annual Meeting, Clin Infect Dis, 25, 383
Jernigan, 1997, The changing spectrum of candidemia at a University Hospital. Abstract No. 661, Abstracts of the DSA ISDA 35th Annual Meeting, Clin Infect Dis, 25, 477
Kramer, 1997, Fungemia at a Community Hospital, Clin Infect Dis, 25, 210
Bodnar, 1996, Ten year evolution of susceptibility in yeast isolates to azole agents. Abstract No. 81, Abstracts of the IDSA 34th Annual Meeting, Clin Infect Dis, 23, 874
Wingard, 1991, Increase in Candida krusei among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole, N Engl J Med, 325, 1274, 10.1056/NEJM199110313251803
Berger, 1998, Epidemic mit Candida krusei an einer hämatologischer Abteilung, Schweiz Med Wochenschrift, 118, 37
Mertz, 1986, Increased incidence of fungemia caused by C. krusei, J Clin Microbiol, 24, 581, 10.1128/jcm.24.4.581-584.1986
Casasnovas, 1992, Prophylactic fluconazole and Candida krusei infection, N Engl J Med, 326, 891, 10.1056/NEJM199203263261312
Case, 1991, Prophylactic oral fluconazole and Candida fungemia, Lancet, 337, 790, 10.1016/0140-6736(91)91406-K
Persons, 1991, Fluconazole and C. krusei fungemia, N Engl J Med, 325, 1315, 10.1056/NEJM199110313251814
Tumbarello, 1999, Candidemia in HIV-infected subjects, Eur J Clin Microbiol Infect Dis, 18, 478, 10.1007/s100960050327
Horn, 1985, Fungemia in a cancer hospital: Changing frequency, earlier onset results of therapy, Rev Infect Dis, 7, 646, 10.1093/clinids/7.5.646
McIllroy, 1991, Failure of fluconazole to supress fungemia in a patient with fever, neutropenia and typhilitis, J Infect Dis, 163, 420, 10.1093/infdis/163.2.420
McQuillen, 1992, Invasive Infections due to Candida krusei. Report of 10 cases of fungemia that include three cases of endophthalmitis, Clin Infect Dis, 14, 485, 10.1093/clinids/14.2.472
Diggs, 1976, Fungal infections of muscle in acute leukemia, Cancer, 38, 1771, 10.1002/1097-0142(197610)38:4<1771::AID-CNCR2820380452>3.0.CO;2-T
Gordon, 1980, Intraabdominal abscess and fungemia caused by Candida krusei (letter), Arch Intern Med, 140, 1239, 10.1001/archinte.1980.00330200115032
Rubenstein, 1975, Fungal endocarditis: analysis of 24 cases and review of the literature, Medicine, 54, 331
Nguyen, 1987, Candida krusei infectious arthritis—a rare complication of neutropenia, Am J Med, 83, 963, 10.1016/0002-9343(87)90660-7
Carcassi, 1982, Artrite acuta da Candida -isolamento di Candida krusei in un eroinomane, Minerva Med, 73, 2905
Thomalla, 1998, Ureteral obstruction of a renal allograft secondary to Candida krusei, Transplant Proc 3, 20, 551
Slavin, 1995, Efficacy and safety of fluconazole prophylaxis for fungal infections after bone marrow transplantation recipients: a prospective randomized doubleblind study, J Infect Dis, 171, 1545, 10.1093/infdis/171.6.1545
Goodman, 1991, Prospective study of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 324, 1311
Powderly, 1988, Amphotericin B-resistant yeast infection in severely immunocompromised patients, Am J Med, 84, 826, 10.1016/0002-9343(88)90059-9
Gumbo, 1999, Candida glabrata fungemia. Clinical features of 139 patients, Medicine, 78, 220, 10.1097/00005792-199907000-00002
McDonald, 1998, Risk factors for candidemia in a children's hospital, Clin Infect Dis, 26, 642, 10.1086/514580
Wingard, 1993, Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients, Antimicrob Agents Chemother, 37, 1847, 10.1128/AAC.37.9.1847
Krcmery, 1999, Candida (Torulopsis) glabrata—an emerging pathogen in cancer patients, Int J Antimicrob Agents, 10, 1, 2, 6
Kridl, 1994, Renal abscess and fungemia due to T. glabrata: successful treatment with drainage and fluconazole, Clin Infect Dis, 18, 116, 10.1093/clinids/18.1.116
Krcmery, 1996, Torulopsis glabrata fungemia in a pregnant woman successfully treated with fluconazole, J Chemother, 8, 89
Weems, 1992, Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations and antimicrobial susceptibility, Clin Infect Dis, 14, 756, 10.1093/clinids/14.3.756
Girmenia, 1996, Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors and differential pathogenicity of the causative strains, Clin Infect Dis, 23, 506, 10.1093/clinids/23.3.506
Plouffe, 1977, Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions, Arch Intern Med, 13, 1686, 10.1001/archinte.1977.03630240022010
Solomon, 1986, Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices, Pediatr Infect Dis, 5, 680, 10.1097/00006454-198611000-00016
Solomon, 1984, An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition, J Infect Dis, 149, 98, 10.1093/infdis/149.1.98
McCray, 1986, Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation, J Clin Microbiol, 24, 625, 10.1128/jcm.24.4.625-628.1986
Stern, 1985, Epidemic postsurgical Candida parapsilosis endophthalmitis: clinical findings and management of 15 consequtive cases, Ophthalmology, 92, 1701, 10.1016/S0161-6420(85)34095-2
Krcmery, 1998, Candida parapsilosis fungemia in cancer patients, Neoplasma, 45, 336
Edwards, 1997, International Conference for the development of a consensus on the Management and Prevention of Severe Candidal Infections, Clin Infect Dis, 25, 43, 10.1086/514504
Clancy, 1998, Molecular epidemiology of candidaemia. Abstract No. 589, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 1032
Rex, 1998, Susceptibility testing of current Candida bloodstream isolates from MSGCS 34. Isolates of C. krusei are often resistant to both fluconazole and amphotericin B. Abstract No. 324, Abstracts of the IDSA 36th Annual Meeting, Clin Infect Dis, 27, 981
Pappagianis, 1979, Development of resistance to amphotericin B in Candida lusitaniae infecting a human, Antimicrob Agents Chemother, 16, 123, 10.1128/AAC.16.2.123
Merz, 1984, Candida lusitaniae, frequency of recovery colonization, infection, and amphotericin B resistance, J Clin Microbiol, 20, 1194, 10.1128/jcm.20.6.1194-1195.1984
Christenson, 1987, Candida lusitaniae: An emerging human pathogen, Pediatr Infect Dis J, 6, 755, 10.1097/00006454-198708000-00013
Favel, 1997, In-vitro susceptibility pattern of Candida lusitaniae and evaluation of the e test method, J Antimicrob Chemother, 39, 591, 10.1093/jac/39.5.591
Guinet, 1983, Fatal septicemia due to amphotericin B resistant, Candida lusitaniae. J Clin Microbiol, 18, 443, 10.1128/jcm.18.2.443-444.1983
Hadfield, 1987, Mycoses caused by Candida lusitaniae, Rev Infect Dis, 9, 1006, 10.1093/clinids/9.5.1006
Walsh, 1991, Empiric therapy with amphotericin B in febrile granulocytopenic patients, Rev Infect Dis, 13, 496, 10.1093/clinids/13.3.496
Verfaillie, 1991, Candida infections in bone marrow transplant recipients, Bone Marrow Transpl, 8, 177
Krcmery, 1999, Fungemia due to C. lusitaniae in cancer patients, FEMS Clin Microbiol Immunol Letters, 29, 75, 10.1111/j.1574-695X.1999.tb01719.x
Krcmery, 1999, Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution, Support Care Cancer, 7, 428, 10.1007/s005200050304
Sufliarsky, 1995, Breakthrough fungemia caused byCandida stellatoidea in a patient with lymphoma associated with shock, successfully treated with amphotericin B lipid complex, Infection, 23, 246, 10.1007/BF01781209
Quindos, 1994, Fatal Candida famata peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis who was treated with fluconazole, Clin Infect Dis, 18, 658, 10.1093/clinids/18.4.658
Carrega, 1997, Candida famata in a surgical patient succesfully treated with fluconazole, Eur J Clin Microbiol Infect Dis, 16, 698, 10.1007/BF01708564
Krcmery, 2000, Candida famata fungemia in a cancer patient: case report, J Chemother, 12, 189, 10.1179/joc.2000.12.2.189
Sugar, 1985, Candida rugosa in immunocompromised cancer patients. Case reports, drug susceptibility and review of the literature, Cancer, 56, 318, 10.1002/1097-0142(19850715)56:2<318::AID-CNCR2820560219>3.0.CO;2-4
Guymon, 1991
Reinhardt, 1985, Intravenous catheter associated fungemia due to, Candida rugosa. J Clin Microbiol, 22, 1056, 10.1128/jcm.22.6.1056-1057.1985
Wingard, 1994, Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy, Clin Infect Dis, 19, 49, 10.1093/clinids/19.Supplement_1.S49
Meis, 1999, Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation, Emerging Infectious Disease, 5, 150, 10.3201/eid0501.990119
Coleman, 1997, Candidiasis: the emergence of a novel species, Candida dubliniensis, AIDS, 11, 557, 10.1097/00002030-199705000-00002
Collin, 1999, Antifungal resistance in non-albicans Candida species, Drug Resistance Update, 2, 9, 10.1054/drup.1998.0059
Morgan, 1996, Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis, Antimicrob Agents Chemother, 42, 1819, 10.1128/AAC.42.7.1819
Sandven, 1997, Candida norvegensis: a Fluconazole-resistant species, Antimicrob Agents Chemother, 41, 1375, 10.1128/AAC.41.6.1375